#NasdaqETFUpdate Donald Trump has been buying a lot of $ETH lately, leveraging the dips he created using tariffs as a weapon.

Another bullish catalyst is the Nasdaq-listed BioNexus Gene Lab approving $ETH as its primary treasury asset, signaling growing institutional confidence in $ETH.

With this, $ETH is trading above $2250 after dipping below $2000 yesterday.

The RWA narrative is set to dominate 2025 and beyond, making this potentially the last time $ETH is available at these levels.

It’s time to take some risk and load up our long-term bags before the market leaves these prices behind.